DAWNRAYS PHARMA (02348) repurchased 216,000 shares on October 27 for HK$202,200.
DAWNRAYS PHARMA (02348) announced that on October 27, 2026, the company repurchased 216,000 shares for HK$202,200.
DAWNRAYS PHARMA (02348) announced that on October 27, 2026, the company repurchased 216,000 shares for HK$202,200.
Related Articles
XIAOMI-W (01810) repurchased 1.9546 million shares on October 27 for HK$49.995 million.
Shanghai Fosun Pharmaceutical (02196) Announces First Three Quarters Results: Net Profit Attributable to Shareholders RMB2.667 billion, Up 5.71% Year-on-Year
AV CONCEPT HOLD (00595) appoints Yip Hing Lam as Chief Operating Officer
XIAOMI-W (01810) repurchased 1.9546 million shares on October 27 for HK$49.995 million.
Shanghai Fosun Pharmaceutical (02196) Announces First Three Quarters Results: Net Profit Attributable to Shareholders RMB2.667 billion, Up 5.71% Year-on-Year
AV CONCEPT HOLD (00595) appoints Yip Hing Lam as Chief Operating Officer
